NCT04052048 - Active Surveillance SNEP Assay Registry Trial for Prostate Cancer | Biotech Hunter

Enrollment

2,000

Participants

Timeline

Start Date

September 9, 2019

Primary Completion Date

November 15, 2025

Study Completion Date

September 30, 2029

Conditions

Prostate Cancer Aggressiveness

Interventions

DIAGNOSTIC_TEST

Subtraction Normalized Expression of Phagocytes Blood Test

Non-invasive blood based immunogenomic assay that targets RNA sequencing to identify disease and disease aggressiveness

Trial Locations (1)

RECRUITING

Comprehensive Urology, Royal Oak